Considering that prolonged exposure to TGF-β promotes EMT in many cancer cell lines [41], we investigated whether platelet-derived TGF-β could activate TGF-β/Smad and Snail signaling in breast tumor cells from patients with luminal A and B and HER2+ subtypes. The gene discussed is SNAI1; the disease is breast neoplasm.